0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Parkinson's Disease- Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-330
Home | Market Reports |Health |Health Conditions |Neurological Conditions
Parkinsons Disease Epidemiology Forecast to 2028

Parkinson's Disease- Epidemiology Forecast to 2028

Code: DELV-Epid-330
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Parkinson's Disease - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Parkinson's Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Parkinson's Disease Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Parkinson's Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Parkinson's Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Parkinson's Disease scenario.

Parkinson's Disease Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Parkinson's Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Parkinson's Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Parkinson's Disease Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Parkinson's Disease

Key assessments
• Patient Segmentation in Parkinson's Disease
• Parkinson's Disease Risk & Burden
• Factors driving growth in a specific Parkinson's Disease patient population

1. Report Introduction
2. Parkinson's Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Parkinson's Disease in 2016
2.2. Patient Share Distribution of Parkinson's Disease in 2028
3. Disease Background and Overview: Parkinson's Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Parkinson's Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Parkinson's Disease in 7MM – By Countries
5. Epidemiology of Parkinson's Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Parkinson's Disease
5.1.3. Sub-Type Specific cases of the Parkinson's Disease *
5.1.4. Sex- Specific Cases of the Parkinson's Disease *
5.1.5. Diagnosed Cases of the Parkinson's Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Parkinson's Disease
5.4.3. Sub-Type Specific cases of the Parkinson's Disease *
5.4.4. Sex- Specific Cases of the Parkinson's Disease *
5.4.5. Diagnosed Cases of the Parkinson's Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Parkinson's Disease
5.5.3. Sub-Type Specific cases of the Parkinson's Disease *
5.5.4. Sex- Specific Cases of the Parkinson's Disease *
5.5.5. Diagnosed Cases of the Parkinson's Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Parkinson's Disease
5.6.3. Sub-Type Specific cases of the Parkinson's Disease *
5.6.4. Sex- Specific Cases of the Parkinson's Disease *
5.6.5. Diagnosed Cases of the Parkinson's Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Parkinson's Disease
5.7.3. Sub-Type Specific cases of the Parkinson's Disease *
5.7.4. Sex- Specific Cases of the Parkinson's Disease *
5.7.5. Diagnosed Cases of the Parkinson's Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Parkinson's Disease
5.8.3. Sub-Type Specific cases of the Parkinson's Disease *
5.8.4. Sex- Specific Cases of the Parkinson's Disease *
5.8.5. Diagnosed Cases of the Parkinson's Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Parkinson's Disease
5.9.3. Sub-Type Specific cases of the Parkinson's Disease *
5.9.4. Sex- Specific Cases of the Parkinson's Disease *
5.9.5. Diagnosed Cases of the Parkinson's Disease
6. Unmet Needs of the Parkinson's Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Parkinson's Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Parkinson's Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Parkinson's Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Parkinson's Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Parkinson's Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Parkinson's Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Parkinson's Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Parkinson's Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Parkinson's Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Parkinson's Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Parkinson's Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Parkinson's Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Parkinson's Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Parkinson's Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Parkinson's Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Parkinson's Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Parkinson's Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Parkinson's Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Parkinson's Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Parkinson's Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Parkinson's Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Parkinson's Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Parkinson's Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Parkinson's Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Parkinson's Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Parkinson's Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Parkinson's Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Parkinson's Disease in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Parkinson's Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Parkinson's Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Parkinson's Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Parkinson's Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Parkinson's Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Parkinson's Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Parkinson's Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Parkinson's Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Parkinson's Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Parkinson's Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Parkinson's Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Parkinson's Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Parkinson's Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Parkinson's Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Parkinson's Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Parkinson's Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Parkinson's Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Parkinson's Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Parkinson's Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Parkinson's Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Parkinson's Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Parkinson's Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Parkinson's Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Parkinson's Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Parkinson's Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Parkinson's Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Parkinson's Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Parkinson's Disease in Japan (2016-2028)

 

SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Levodopa Sales Market Report 2021
Global Levodopa Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-1P5137
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Cholinesterase Inhibitors Sales Market Report 2021
Global Cholinesterase Inhibitors Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-13B5368
Mon Jun 14 00:00:00 UTC 2021

Add to Cart

Global Essential Tremor Treatment Market Insights and Forecast to 2027
Global Essential Tremor Treatment Market Insights and Forecast to 2027

The market size will reach US 205 million by the end of 2026 growing at a CAGR of 5.1 during 20212026.Global Essential Tremor Treatment Scope and Market SizeEssential Tremor Treatment market is segmented by Type and by Application.

120 Pages
Type: Report
Code: QYRE-Auto-041
Fri Jun 11 00:00:00 UTC 2021

Add to Cart

Global Gabapentin Market Insights and Forecast to 2027
Global Gabapentin Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-16D300
Thu Jun 10 00:00:00 UTC 2021

Add to Cart